Cordyceps Sinensis Extract Market Size and Share to Project Lucrative CAGR By 2020 | Future Growth Trends, Key Players Profile, Business Insights, Overview, Growth Projection and Global Market Analysis By 2026
Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Cordyceps sinensis, also known as ophiocordyceps sinensis, is combination of parasitic fungus species and dead caterpillars that offer several potential health applications. It has been described as a medicine in old Chinese medical books and Tibetan medicine for the treatment of around 21 ailments such as low immunity and high blood pressure. Cordyceps spores grows inside the caterpillar’s body and infects it. It gradually degrades the living larva and mummifies it in the soil and a cordyceps stem emerges from head part of the caterpillar.
Some of the active ingredients in cordyceps sinensis extract include, cordycepin, adenosine, exopolysaccharide fraction (EPSF), cordyglucans, and monosaccharide saponin. Several research studies and clinical trials have concluded that cordyceps sinensis extract can aid in the treatment of several diseases such as diabetes, high cholesterol, and hypertension. Cordyceps sinensis also increases immunity and can relive stress, thereby finding application in the tenement of stress related disorders.
Cordyceps sinensis is available in various forms such as tablet, powder, and capsule. Several regulatory bodies worldwide such as the U.S. FDA has approved the use of cordyceps sinensis extract as dietary supplement.
*The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1983
Cordyceps Sinensis Extract Market- Market Dynamics
Cordyceps sinensis has several medicinal properties such as cholesterol reduction, stimulation of the immune system, faster recovery from bronchitis and other respiratory diseases, and boosting efficiency of the circulatory system. It can also be used in the treatment of cancer and liver-associated diseases as it offers fast recovery from chemotherapy and improves libido, a general body adaptogen (enhanced body energy and strength)
High prevalence of chronic diseases such as cardiovascular disease, cancer, diabetes, and respiratory diseases is expected to aid in growth of the cordyceps sinensis extract market. For instance, according to the World Health Organization’s statistics in 2018, non-communicable diseases are responsible for over 41 million deaths, annually, which is equivalent to 71% of all deaths, worldwide. Furthermore, according to the same source, cardiovascular diseases causes over 17.9 million deaths, annually, followed by cancer (9.0 million), respiratory diseases (3.9million), and diabetes (1.6 million), respectively.
High prevalence of autoimmune and stress related disorders is also expected to boost the market growth, especially in developed regions such as North America and Europe. For instance, according to the American Autoimmune Related Disease Association, more than 50 million people in the U.S. were affected by autoimmune disease in 2017.
However, high cost of cordyceps sinensis extracts is expected to hamper the market growth. Moreover, absence of solid proof of efficiency of the extract in the treatment of several diseases such as cancer and diabetes may also restrict the market growth. Increasing the artificial cultivation of cordyceps sinensis species is filled with several challenges. High cost of cordyceps sinensis in the international market often leads to malpractice of adulteration and substitution in the extracts.
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1983
Cordyceps Sinensis Extract Market- Regional Insights
On the basis of region, the global cordyceps sinensis extract market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in the market during the forecast period, followed by Europe. The market in North America is driven by increasing prevalence of chronic diseases in the U.S. For instance, according to the Centers for Disease Control and Prevention, seven of the top ten causes of deaths in the U.S. in 2014 were chronic diseases, heart diseases, and cancer, which together accounted for over 46% of the deaths in the country. Moreover, high prevalence of mental disorders is also expected to contribute to the market growth as cordyceps sinensis extracts can reduce the symptoms related to mental disorders. For instance, according to Anxiety and Depression Association of America in 2017, anxiety disorders are the most common mental illness in the U.S., affecting around 40 million adults aged 18 years and above, or 18.1% of the population, annually. However, only 36.9% of those suffering from anxiety receive treatment.
The market in Asia Pacific is expected to witness significant growth over the forecast period as the region is major producer of cordyceps sinensis extracts, especially in China. For instance, according to the data presented by the Ministry of Agriculture and Rural Affairs of the People’s Republic of China in 2011, China has 200,000 kg of cordyceps sinensis and 120,000 kg was harvested. Qinghai and Tibet regions export around 20,000 kg of cordyceps sinensis to countries such as the U.S., Japan, Korea, Hong Kong, Macao, and Taiwan and some countries in Europe and South East Asia with an annual export of over 20,000 kg. Moreover, increasing prevalence of chronic diseases and preference for traditional medicines for the treatment of such diseases in the region is expected to boost growth of the cordyceps sinensis extract market.
Cordyceps Sinensis Extract Market- Competitive Landscape
Key players operating in the global cordyceps sinensis market include, Naturalin, Active Organics, Quyuan sunnycare Inc., Kangzhou, HERBSINO, SOST, Health Choice Limited, Zhongke Group, and Nutra Green.
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/1983
Cordyceps Sinensis Extract Market – Market Taxonomy
On the basis of dosage form, the global cordyceps sinensis extract market is segmented into –
On the basis of application, the global cordyceps sinensis extract market is segmented into -:
- Dietary supplement
- Medicinal use
On the basis of distribution channel, the global cordyceps sinensis extract market is segmented into -:
- Retail Pharmacy
- Online Pharmacy
On the basis of geography, the global cordyceps sinensis extract market is segmented into-:
- North America
- Latin America
- Asia Pacific
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire